Evidence map›Paper›PMID 40631062›Full record

ArticleFrontiers in psychology2025

Development and preliminary evaluation of Chinese Vitiligo Quality of Life Scale (CVQLS).

Bo Wang, Qi Wang, Zeqian Wang, Jia Zhang, Yuqi Zhou, Xiaoqi Chen, Tong Wu, Shishi Xiong, Xiaodong Jin, Shanshan Gao and 3 more

Abstract read
In one paragraph

Article in Frontiers in psychology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Bo WangDepartment of Dermatology, Xijing Hospital, Fourth Military Medical University, Xi'an, Shaanxi, China.
Qi WangDepartment of Dermatology, Xijing Hospital, Fourth Military Medical University, Xi'an, Shaanxi, China.
Zeqian WangDepartment of Dermatology, Xijing Hospital, Fourth Military Medical University, Xi'an, Shaanxi, China.
Jia ZhangDepartment of Dermatology, Xijing Hospital, Fourth Military Medical University, Xi'an, Shaanxi, China.
Yuqi ZhouDepartment of Dermatology, Xijing Hospital, Fourth Military Medical University, Xi'an, Shaanxi, China.
Xiaoqi ChenDepartment of Dermatology, Xijing Hospital, Fourth Military Medical University, Xi'an, Shaanxi, China.
Tong WuDepartment of Dermatology, Xijing Hospital, Fourth Military Medical University, Xi'an, Shaanxi, China.
Shishi XiongDepartment of Dermatology, Xijing Hospital, Fourth Military Medical University, Xi'an, Shaanxi, China.
Xiaodong JinDepartment of Dermatology, Xijing Hospital, Fourth Military Medical University, Xi'an, Shaanxi, China.
Shanshan GaoDepartment of Dermatology, Xijing Hospital, Fourth Military Medical University, Xi'an, Shaanxi, China.
Lei ShangDepartment of Health Statistics, School of Public Health, Fourth Military Medical University, Xi'an, Shaanxi, China.
Chunying LiDepartment of Dermatology, Xijing Hospital, Fourth Military Medical University, Xi'an, Shaanxi, China.
Zhe JianDepartment of Dermatology, Xijing Hospital, Fourth Military Medical University, Xi'an, Shaanxi, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Current research shows that there is no vitiligo quality-of-life measurement instrument suitable for Chinese patients. At present, the DLQI scale commonly used with vitiligo patients in China includes symptom dimensions or items that are not applicable to vitiligo patients. Therefore, it is necessary to develop a quality-of-life scale specific to vitiligo patients in China. Methods: In this study, the item pool was created through a comprehensive review of relevant literature, focus group discussions, and brainstorming. Two rounds of Delphi expert consultation and a semi-structured interview were conducted to modify the item pool and form the draft scale. Two rounds of questionnaire investigations were used to select items and form the final scale. The reliability, validity, and discriminative ability were evaluated based on the third round of questionnaire investigation. Results: The scale contains 3 dimensions and 25 items, and the total cumulative variance contribution rate was 64.54%. The Cronbach's Conclusion: This study developed the Chinese Vitiligo Quality of Life Scale (CVQLS) to measure the quality of life of vitiligo patients in China. Compared to the commonly used DLQI, the CVQLS removed items related to skin disease symptoms while incorporating concerns specific to Chinese patients, such as the economic burden. The scale is thus tailored to the needs of Chinese vitiligo patients. Preliminary results indicate that the CVQLS has good reliability, validity, and discriminative ability.

Indexed as

construct validitycriterion-related validitydiscriminative abilityquality of lifescale developmentsplit-half reliabilitytest–retest reliabilityvitiligo

Identifiers

PMID40631062
PMCPMC12236179

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.